(1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency.

MLA

Wujcik, K., et al. “(1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency.” Journal of Heart & Lung Transplantation, vol. 43, no. 4, Apr. 2024, pp. S623–24. EBSCOhost, https://doi.org/10.1016/j.healun.2024.02.970.

APA

Wujcik, K., Barkoff, L., Lee, J., Hollander, S. A., Chen, C., Gonzales, S., Profita, E., & Almond, C. (2024). (1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency. Journal of Heart & Lung Transplantation, 43(4), S623–S624. https://doi.org/10.1016/j.healun.2024.02.970

Chicago

Wujcik, K., L. Barkoff, J. Lee, S.A. Hollander, C. Chen, S. Gonzales, E. Profita, and C. Almond. 2024. “(1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency.” Journal of Heart & Lung Transplantation 43 (4): S623–24. doi:10.1016/j.healun.2024.02.970.